Annual CFF
$5.22 M
-$8.79 M-62.76%
December 31, 2023
Summary
- As of February 7, 2025, QNRX annual cash flow from financing activities is $5.22 million, with the most recent change of -$8.79 million (-62.76%) on December 31, 2023.
- During the last 3 years, QNRX annual CFF has risen by +$3.43 million (+191.84%).
- QNRX annual CFF is now -62.76% below its all-time high of $14.01 million, reached on December 31, 2022.
Performance
QNRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$149.90 K
-$13.60 K-9.98%
September 30, 2024
Summary
- As of February 7, 2025, QNRX quarterly cash flow from financing activities is -$149.90 thousand, with the most recent change of -$13.60 thousand (-9.98%) on September 30, 2024.
- Over the past year, QNRX quarterly CFF has dropped by -$5.48 million (-102.81%).
- QNRX quarterly CFF is now -101.02% below its all-time high of $14.75 million, reached on September 30, 2022.
Performance
QNRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$4.86 M
+$125.10 K+2.64%
September 30, 2024
Summary
- As of February 7, 2025, QNRX TTM cash flow from financing activities is $4.86 million, with the most recent change of +$125.10 thousand (+2.64%) on September 30, 2024.
- Over the past year, QNRX TTM CFF has increased by +$63.80 thousand (+1.33%).
- QNRX TTM CFF is now -80.32% below its all-time high of $24.71 million, reached on September 30, 2022.
Performance
QNRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
QNRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -62.8% | -102.8% | +1.3% |
| 3 y3 years | +191.8% | -102.6% | -75.6% |
| 5 y5 years | +301.7% | -102.6% | -75.6% |
QNRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.8% | at low | -101.0% | +66.5% | -80.3% | +2.6% |
| 5 y | 5-year | -62.8% | +301.7% | -101.0% | +66.5% | -80.3% | +271.3% |
| alltime | all time | -62.8% | +301.7% | -101.0% | +66.5% | -80.3% | +271.3% |
Quoin Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$149.90 K(+10.0%) | $4.86 M(+2.6%) |
| Jun 2024 | - | -$136.30 K(-102.6%) | $4.74 M(-1.3%) |
| Mar 2024 | - | $5.33 M(-3020.3%) | $4.80 M(-8.0%) |
| Dec 2023 | $5.22 M(-62.8%) | -$182.60 K(-33.6%) | $5.22 M(+5.3%) |
| Sep 2023 | - | -$275.00 K(+266.7%) | $4.95 M(-75.2%) |
| Jun 2023 | - | -$75.00 K(-101.3%) | $19.98 M(+0.4%) |
| Mar 2023 | - | $5.75 M(-1386.5%) | $19.91 M(+42.1%) |
| Dec 2022 | $14.01 M | -$446.90 K(-103.0%) | $14.01 M(-43.3%) |
| Sep 2022 | - | $14.75 M(<-9900.0%) | $24.71 M(+149.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$150.00 K(0.0%) | $9.91 M(-17.8%) |
| Mar 2022 | - | -$150.00 K(-101.5%) | $12.04 M(-10.8%) |
| Dec 2021 | $13.50 M(+655.5%) | - | - |
| Dec 2021 | - | $10.26 M(<-9900.0%) | $13.50 M(+316.1%) |
| Sep 2021 | - | -$52.80 K(-102.7%) | $3.25 M(-1.6%) |
| Jun 2021 | - | $1.99 M(+51.8%) | $3.30 M(+151.8%) |
| Mar 2021 | - | $1.31 M | $1.31 M |
| Dec 2020 | $1.79 M(+37.6%) | - | - |
| Dec 2019 | $1.30 M | - | - |
FAQ
- What is Quoin Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual CFF year-on-year change?
- What is Quoin Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly CFF year-on-year change?
- What is Quoin Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals TTM CFF year-on-year change?
What is Quoin Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of QNRX is $5.22 M
What is the all time high annual CFF for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual cash flow from financing activities is $14.01 M
What is Quoin Pharmaceuticals annual CFF year-on-year change?
Over the past year, QNRX annual cash flow from financing activities has changed by -$8.79 M (-62.76%)
What is Quoin Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of QNRX is -$149.90 K
What is the all time high quarterly CFF for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly cash flow from financing activities is $14.75 M
What is Quoin Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, QNRX quarterly cash flow from financing activities has changed by -$5.48 M (-102.81%)
What is Quoin Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of QNRX is $4.86 M
What is the all time high TTM CFF for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high TTM cash flow from financing activities is $24.71 M
What is Quoin Pharmaceuticals TTM CFF year-on-year change?
Over the past year, QNRX TTM cash flow from financing activities has changed by +$63.80 K (+1.33%)